In today's fast-paced world, finding an effective and safe way to manage weight can often feel overwhelming. With countless ...

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Viking thinks the oral alternative offers a smooth transition from the subcutaneous form and might appeal to individuals ...